1 - 10 out of 20Page size: 10
  1. 2023

  2. Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV

    Verburgh, M. L., van Pul, L., Grobben, M., Boyd, A., Wit, F. W. N. M., van Nuenen, A. C., van Dort, K. A., Tejjani, K., van Rijswijk, J., Bakker, M., van der Hoek, L., Schim van der Loeff, M. F., van der Valk, M., van Gils, M. J., Kootstra, N. A. & Reiss, P., 11 May 2023, (E-pub ahead of print) In: Microbiology spectrum. p. e0115523

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Vaccination from the early second trimester onwards gives a robust SARS-CoV-2 antibody response throughout pregnancy and provides antibodies for the neonate

    Zilver, S. J. M., de Groot, C. J. M., Grobben, M., Remmelzwaal, S., Burgers, E., Velasco, D. N., Juncker, H. G., van Keulen, B. J., van Goudoever, J. B., de Leeuw, R. A., van Gils, M. J., Ris-Stalpers, C. & van Leeuwen, E., 1 May 2023, In: International Journal of Infectious Diseases. 130, p. 126-135 10 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity

    VACOPID Research Group, 2023, (E-pub ahead of print) In: Journal of clinical immunology.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. 2022

  6. Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection

    Brouwer, P. J. M., Antanasijevic, A., Ronk, A. J., Müller-Kräuter, H., Watanabe, Y., Claireaux, M., Perrett, H. R., Bijl, T. P. L., Grobben, M., Umotoy, J. C., Schriek, A. I., Burger, J. A., Tejjani, K., Lloyd, N. M., Steijaert, T. H., van Haaren, M. M., Sliepen, K., de Taeye, S. W., van Gils, M. J., Crispin, M., & 4 othersStrecker, T., Bukreyev, A., Ward, A. B. & Sanders, R. W., 14 Dec 2022, In: Cell host & microbe. 30, 12, p. 1759-1772.e12

    Research output: Contribution to journal › Article › Academic › peer-review

  7. A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike

    Claireaux, M., Caniels, T. G., de Gast, M., Han, J., Guerra, D., Kerster, G., van Schaik, B. D. C., Jongejan, A., Schriek, A. I., Grobben, M., Brouwer, P. J. M., van der Straten, K., Aldon, Y., Capella-Pujol, J., Snitselaar, J. L., Olijhoek, W., Aartse, A., Brinkkemper, M., Bontjer, I., Burger, J. A., & 13 othersPoniman, M., Bijl, T. P. L., Torres, J. L., Copps, J., Martin, I. C., de Taeye, S. W., de Bree, G. J., Ward, A. B., Sliepen, K., van Kampen, A. H. C., Moerland, P. D., Sanders, R. W. & van Gils, M. J., 1 Dec 2022, In: Nature communications. 13, 1, 4539.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike

    van der Velden, Y. U., Grobben, M., Caniels, T. G., Burger, J. A., Poniman, M., Oomen, M., Rijnstra, E. S., Tejjani, K., Guerra, D., Kempers, R., Stegmann, T., van Gils, M. J. & Sanders, R. W., 1 Dec 2022, In: Scientific reports. 12, 1, 3884.

    Research output: Contribution to journal › Article › Academic › peer-review

  9. Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions (Front. Immunol., (2022), 13, 893648, 10.3389/fimmu.2022.893648)

    Schriek, A. I., van Haaren, M. M., Poniman, M., Dekkers, G., Bentlage, A. E. H., Grobben, M., Vidarsson, G., Sanders, R. W., Verrips, T., Geijtenbeek, T. B. H., Heukers, R., Kootstra, N. A., de Taeye, S. W. & van Gils, M. J., 22 Nov 2022, In: Frontiers in immunology. 13, 1091668.

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  10. Older people with well-controlled HIV have similar antibody and higher T-cell responses after vaccination against SARS-CoV-2 compared to demographically and lifestyle-comparable people without HIV

    Verburgh, M., van Pul, L., Grobben, M., Boyd, A., Wit, F., van Nuenen, A., van Dort, K., Tejjani, K., van Rijswijk, J., Bakker, M., van der Hoek, L., van der Loeff, M. S., van der Valk, M., van Gils, M., Kootstra, N. & Reiss, P., 1 Oct 2022, In: Journal of the International AIDS Society. 25, 6, SI, p. 7-9 3 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children

    Keuning, M. W., Grobben, M., Bijlsma, M. W., Anker, B., Berman-de Jong, E. P., Cohen, S., Felderhof, M., de Groen, A-E., de Groof, F., Rijpert, M., van Eijk, H. W. M., Tejjani, K., van Rijswijk, J., Steenhuis, M., Rispens, T., Plötz, F. B., van Gils, M. J. & Pajkrt, D., 9 Sept 2022, In: Frontiers in immunology. 13, 976382.

    Research output: Contribution to journal › Article › Academic › peer-review

  12. Decreased Passive Immunity to Respiratory Viruses through Human Milk during the COVID-19 Pandemic

    Grobben, M., Juncker, H. G., van der Straten, K., Lavell, A. H. A., Schinkel, M., Buis, D. T. P., Wilbrink, M. F., Tejjani, K., Claireaux, M. A. F., Aartse, A., de Groot, C. J. M., Pajkrt, D., Bomers, M. K., Sikkens, J. J., van Gils, M. J., van Goudoever, J. B. & van Keulen, B. J., 31 Aug 2022, In: Microbiology spectrum. 10, 4, p. e0040522

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 Next

ID: 6062180